Jagsonpal Pharma

{
  "main_header": {
    "sid": 134241,
    "name": "Jagsonpal Pharma",
    "stock_name": "Jagsonpal Pharma",
    "full_name": "Jagsonpal Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/jagsonpal-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "228.00",
    "chg": 0.25,
    "chgp": "0.11%",
    "dir": 1,
    "prev_price": "227.75",
    "mcapval": "1,515.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 507789,
    "symbol": "JAGSNPHARM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE048B01035",
    "curr_date": "Sep 18, 03:30 PM",
    "curr_time": "02:13 AM",
    "last_traded_at": "Sep 18, 03:30 PM IST",
    "bse_nse_vol": "50.99 k",
    "exc_status": "Active",
    "traded_date": "Sep 18, 2026",
    "traded_date_str": "2026 09 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/jagsonpal-pharma-134241-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Jagsonpal Pharmaceuticals Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/jagsonpal-pharmaceuticals-ltd-is-rated-hold-4190529",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/JagsonpalPharma_mojoScore_4190529.png",
        "date": "2026-09-11 10:10:05",
        "description": "Jagsonpal Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 29 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 September 2026, providing investors with the most up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Jagsonpal Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jagsonpal-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-market-signals-4185436",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/JagsonpalPharma_technicaldot_4185436.png",
        "date": "2026-09-08 08:00:27",
        "description": "Jagsonpal Pharmaceuticals Ltd has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish stance as of early September 2026. Despite a slight dip in daily price, key indicators such as MACD and moving averages continue to support a cautiously optimistic outlook, while other metrics suggest a more tempered trend. This article analyses the recent technical developments and their implications for investors in the pharmaceuticals and biotechnology sector."
      },
      {
        "title": "Jagsonpal Pharmaceuticals Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/jagsonpal-pharmaceuticals-ltd-is-rated-hold-4176122",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/JagsonpalPharma_mojoScore_4176122.png",
        "date": "2026-08-31 10:10:04",
        "description": "Jagsonpal Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 29 July 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 31 August 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Jagsonpal Pharmaceuticals Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/jagsonpal-pharmaceuticals-ltd-is-rated-hold-4162621",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/JagsonpalPharma_mojoScore_4162621.png",
        "date": "2026-08-20 10:10:05",
        "description": "Jagsonpal Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 29 July 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 20 August 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Jagsonpal Pharmaceuticals Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/jagsonpal-pharmaceuticals-ltd-is-rated-hold-4144121",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/JagsonpalPharma_mojoScore_4144121.png",
        "date": "2026-08-09 10:10:04",
        "description": "Jagsonpal Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 29 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Jagsonpal Pharmaceuticals Ltd Technical Momentum Shifts Signal Bullish Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jagsonpal-pharmaceuticals-ltd-technical-momentum-shifts-signal-bullish-outlook-4132772",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/JagsonpalPharma_technicaldot_4132772.png",
        "date": "2026-08-03 08:00:17",
        "description": "Jagsonpal Pharmaceuticals Ltd has witnessed a notable shift in its technical momentum, with key indicators signalling a transition from a mildly bullish to a more confident bullish trend. Despite a recent day decline of 2.68%, the stock’s underlying technical parameters suggest improving momentum that could influence investor sentiment in the coming weeks."
      },
      {
        "title": "Are Jagsonpal Pharmaceuticals Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-jagsonpal-pharmaceuticals-ltd-latest-results-good-or-bad-4129032",
        "imagepath": "",
        "date": "2026-07-30 19:18:55",
        "description": "Jagsonpal Pharmaceuticals Ltd has reported its financial results for Q1 FY27, showcasing notable operational trends. The company achieved a record quarterly revenue of ₹82.23 crores, reflecting a sequential growth of 28.08% compared to the previous quarter. Year-on-year revenue growth was recorded at 8.76%, indicating steady market expansion despite competitive pressures.\n\nNet profit for the quarter stood at ₹13.19 crores, which represents a significant quarter-on-quarter increase of 50.56% and a year-on-year growth of 22.13%. The improvement in profitability is further underscored by an operating margin that expanded to 20.97%, up from 17.38% in the previous quarter, highlighting effective cost management and a favorable product mix.\n\nThe company's return on equity (ROE) is reported at 17.66%, which is above its five-year average, suggesting effective management in generating returns for shareholders. Addi..."
      },
      {
        "title": "Jagsonpal Pharmaceuticals Q1 FY27: Strong Quarter Marred by Expensive Valuation",
        "link": "https://www.marketsmojo.com/news/result-analysis/jagsonpal-pharmaceuticals-q1-fy27-strong-quarter-marred-by-expensive-valuation-4128796",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/JagsonpalPharma_quaterlyResult_4128796.png",
        "date": "2026-07-30 10:01:30",
        "description": "Jagsonpal Pharmaceuticals Ltd. reported a robust first quarter for FY2027, with net profit surging 50.56% quarter-on-quarter to ₹13.19 crores, marking the company's strongest quarterly performance in recent history. The micro-cap pharmaceutical manufacturer, with a market capitalisation of ₹1,651.86 crores, saw its stock rally 8.70% following the results announcement, closing at ₹250.55 on July 30, 2026. However, despite the impressive operational performance, the company's valuation remains stretched at 34 times trailing earnings, raising questions about sustainability of current price levels."
      },
      {
        "title": "Jagsonpal Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/jagsonpal-pharmaceuticals-ltd-is-rated-sell-4125696",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/JagsonpalPharma_mojoScore_4125696.png",
        "date": "2026-07-29 10:11:32",
        "description": "Jagsonpal Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 Jul 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 29 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      }
    ],
    "total": 282,
    "sid": "134241",
    "stock_news_url": "https://www.marketsmojo.com/news/jagsonpal-pharmaceuticals-134241"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "28-Aug-2026",
      "details": "Newspaper Publication for dispatch of Notice of 47th Annual General Meeting Annual Report 2025-26 and e-voting",
      "source": "BSE"
    },
    {
      "caption": "Business Responsibility and Sustainability Reporting (BRSR)",
      "datetime": "27-Aug-2026",
      "details": "BRSR for the Financial year ended March 31 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement Under Regulation 30-SEBI (LODR) Regulations 2015",
      "datetime": "27-Aug-2026",
      "details": "Letter providing a web link of annual report 2025-26 to members.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Jagsonpal Pharmaceuticals Ltd has declared <strong>200%</strong> dividend, ex-date: 04 Sep 26",
          "dt": "2026-09-04",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Jagsonpal Pharmaceuticals Ltd has announced <strong>2:5</strong> stock split, ex-date: 08 Jan 25",
          "dt": "2025-01-08",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Jagsonpal Pharmaceuticals Ltd is Rated Hold

2026-09-11 10:10:05

Jagsonpal Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 29 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 September 2026, providing investors with the most up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Jagsonpal Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-09-08 08:00:27

Jagsonpal Pharmaceuticals Ltd has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish stance as of early September 2026. Despite a slight dip in daily price, key indicators such as MACD and moving averages continue to support a cautiously optimistic outlook, while other metrics suggest a more tempered trend. This article analyses the recent technical developments and their implications for investors in the pharmaceuticals and biotechnology sector.

Read full news article

Jagsonpal Pharmaceuticals Ltd is Rated Hold

2026-08-31 10:10:04

Jagsonpal Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 29 July 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 31 August 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Jagsonpal Pharmaceuticals Ltd is Rated Hold

2026-08-20 10:10:05

Jagsonpal Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 29 July 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 20 August 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Jagsonpal Pharmaceuticals Ltd is Rated Hold

2026-08-09 10:10:04

Jagsonpal Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 29 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Jagsonpal Pharmaceuticals Ltd Technical Momentum Shifts Signal Bullish Outlook

2026-08-03 08:00:17

Jagsonpal Pharmaceuticals Ltd has witnessed a notable shift in its technical momentum, with key indicators signalling a transition from a mildly bullish to a more confident bullish trend. Despite a recent day decline of 2.68%, the stock’s underlying technical parameters suggest improving momentum that could influence investor sentiment in the coming weeks.

Read full news article

Are Jagsonpal Pharmaceuticals Ltd latest results good or bad?

2026-07-30 19:18:55

Jagsonpal Pharmaceuticals Ltd has reported its financial results for Q1 FY27, showcasing notable operational trends. The company achieved a record quarterly revenue of ₹82.23 crores, reflecting a sequential growth of 28.08% compared to the previous quarter. Year-on-year revenue growth was recorded at 8.76%, indicating steady market expansion despite competitive pressures. Net profit for the quarter stood at ₹13.19 crores, which represents a significant quarter-on-quarter increase of 50.56% and a year-on-year growth of 22.13%. The improvement in profitability is further underscored by an operating margin that expanded to 20.97%, up from 17.38% in the previous quarter, highlighting effective cost management and a favorable product mix. The company's return on equity (ROE) is reported at 17.66%, which is above its five-year average, suggesting effective management in generating returns for shareholders. Addi...

Read full news article

Jagsonpal Pharmaceuticals Q1 FY27: Strong Quarter Marred by Expensive Valuation

2026-07-30 10:01:30

Jagsonpal Pharmaceuticals Ltd. reported a robust first quarter for FY2027, with net profit surging 50.56% quarter-on-quarter to ₹13.19 crores, marking the company's strongest quarterly performance in recent history. The micro-cap pharmaceutical manufacturer, with a market capitalisation of ₹1,651.86 crores, saw its stock rally 8.70% following the results announcement, closing at ₹250.55 on July 30, 2026. However, despite the impressive operational performance, the company's valuation remains stretched at 34 times trailing earnings, raising questions about sustainability of current price levels.

Read full news article

Jagsonpal Pharmaceuticals Ltd is Rated Sell

2026-07-29 10:11:32

Jagsonpal Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 Jul 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 29 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

View All News